Genetic testing is the category with the widest gap between marketing and medicine. At the credible end, accredited laboratories offer carrier screening for inherited conditions, pharmacogenomic panels that flag how you metabolise certain medications, and hereditary risk panels for specific cancers — all collectable at home via a cheek swab or blood draw through a licensed provider. At the other end sit lifestyle DNA kits promising to reveal your ideal diet or sport, which are closer to entertainment than to clinical evidence and should be priced in your mind accordingly.
Two UAE-specific points. The premarital screening programme — covering inherited blood disorders such as thalassaemia and sickle cell, which are relatively common in the Gulf — is a formal process at approved government centres, and no home kit replaces it. And a genetic result is a probability statement, not a diagnosis: a raised hereditary risk means structured screening and a conversation with a doctor or genetic counsellor, while a clear result does not mean zero risk, because panels only test the variants they test.